FLGTFulgent Genetics, Inc.
$20.87-7.8% 1Y
$20.87
$13.7952 weeks$30.85
What is the market doing?
Good
1 good, 2 without dataIn an uptrend. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendUptrendderived · Oct 8, 2026
In an uptrend, above its rising 50- and 200-day averages. Price is +5% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How FLGT is trading
Fulgent Genetics, Inc. is −7.8% over the past year while the S&P 500 is +18%: 26 points behind the market.
−7.8%
1-year return · S&P 500 +18%
- vs 200-day average
- +5.0%
vs 200-day average · close to trend
- RSI (14)
- 43
RSI (14) · neutral
- Below its 52-week high
- 32%
Below its 52-week high
Details›
- Last close2026-10-08
- $20.87
- 1 monthS&P 500 +1.6%
- +5.1%
- 1 yearS&P 500 +18%
- −7.8%
- 5 yearsS&P 500 +86%
- −77%
- vs 50-day average$20.13
- +3.7%
- 52-week high
- $30.85
- 52-week low
- $13.79
- Annualised volatility
- 54%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$106K
| Year | Return |
|---|---|
| 2026 (year to date) | −21% |
| 2025 | +42% |
| 2024 | −36% |
| 2023 | −2.9% |
| 2022 | −70% |
| 2021 | +93% |
| 2020 | +304% |
| 2019 | +307% |
| 2018 | −28% |
| 2017 | −62% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +11% |
| Feb | 10 | 3 of 10 | −5.3% |
| Mar | 10 | 4 of 10 | −1.5% |
| Apr | 10 | 3 of 10 | +1.4% |
| May | 10 | 5 of 10 | +1.9% |
| Jun | 10 | 6 of 10 | +4.1% |
| Jul | 10 | 6 of 10 | +8.1% |
| Aug | 10 | 4 of 10 | +5.4% |
| Sep | 10 | 3 of 10 | −1.1% |
| Oct | 11 | 1 of 11 | −7.0% |
| Nov | 10 | 6 of 10 | +9.7% |
| Dec | 10 | 7 of 10 | +3.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Diagnostics & Research
Ranks #14 of 21 by RyuScore